|

Development of the Quality Donor System™ (QDS) began in 1992 with the
desktop United Blood Services Windows 3.1 application from which has evolved the current QDS
2004 Release 2.01 web-technology based system. Despite this long history, it was not until the late 1990's that the development and regulatory climate in the United States became sufficiently favorable to permit implementation
of QDS in blood banks.
Talisman Limited has received two Small Business Innovation
Research (SBIR) grants from the National
Heart Lung & Blood Institute (NHLBI) for the purpose of developing
automated donor processing systems with emphasis on audio-visual
touch screen computer assisted donor self interviewing (AVT-CASI).
The first SBIR grant (HL61111) was awarded in 1998 for development of a proof-of-concept
version of the QDS software aimed at improving consistency of the
interview process and reducing or eliminating non-decision making human errors
such as incompleteness,
transposition, key entry, donor literacy and communication errors. Legibility problems
are also addressed by QDS. Thomas F. Zuck, MD of the Hoxworth
Blood Center was co-investigator on this effort. The initial Phase I grant was followed
by a Phase II grant in 2000, under which QDS was re-developed as a
web-based system, installed at a mid-sized blood center (Mississippi
Valley Regional Blood Center, Louis M. Katz, MD, Co-investigator) and
subjected to scientific evaluation.
The second SBIR grant (HL072635) for "Paperless Quality Donor
System with Decision making" was awarded in 2003, with a Phase II
follow-on. Under this grant, QDS was
further refined, including installing it in three more blood centers
and a hospital blood bank. Additional development has included
improving performance in a networked environment, QDS in Spanish, prototyping of
vital signs and phlebotomy functions, and implementation of the new
(2004) AABB Uniform Donor History Questionnaire (UDHQ) including
rudimentary decision aids. Further studies (2004) on system performance and
user preferences corroborated earlier work (2001-2002) establishing that QDS
significantly reduces FDA-reportable errors, reduces staff time for
interviews, improves donor disclosure of risky and stigmatizing
behavior and is strongly preferred by donors and blood center staff
compared to
face-to-face interviewing used prior to QDS adoption.
First SBIR Grant - Computerized
Blood Donor Processing System (HL61111)
In December 1997 Talisman secured FDA agreement that Talisman's
blood donor screening technology was not subject to medical device
regulations. At that point Talisman applied for a SBIR-I grant from
the NHLBI. The grant was awarded in August 1998 with Thomas F. Zuck,
MD, former CBER head and Chief Executive of the University of Cincinnati's
Hoxworth Blood Center as co-investigator. The original Windows 3.1
technology used in the earlier version of the donor self-interviewing
system was updated for Windows 9x compatibility, customized to Hoxworth's
requirements and implemented as a single workstation at the Hoxworth
main center in Cincinnati, OH in February of 1999. The system was custom tailored using Hoxworth's donor history interview and became known as the Hoxworth Quality Donor System™ (HQDS). HQDS software performed as expected and data collected during the pilot study showed that donors had very favorable responses to the system.
Research studies conducted on the HQDS system provided evidence
that donors who have a preference for one system or the other clearly
preferred QDS to the traditional staff administered health history
interview, believed the system provided more privacy and said with
the system they would be more honest and donate more frequently.
The system standardizes the interview process and reduces or eliminates
human errors such as typographical, transposition, incompleteness,
illegibility, and illiteracy.
Results of the pilot study have been published in the
Transfusion, December
2001. (See
also Dr. Zuck's
presentation (with
audio) to the American Association of Blood Banks in late
1999)
In April 2000 Talisman received a Phase II (SBIR-II) two-year grant
to develop a more robust, networked, web-compatible version of QDS
capable of ultimate expansion into a fully automated blood donor
data collection and processing system.
In 2000 agreement was reached with Mississippi Valley
Regional Blood Center, Davenport, IA (MVRBC) for installation of a standardized version of QDS based on
the American Association of Blood Banks (AABB) Uniform Donor History
Questionnaire (UDHQ). In spring 2001 NHLBI provided additional
support and assistance to Talisman in working with FDA/CBER to permit
implementation of the standalone and LAN versions of QDS as a Changes
Being Effected in 30 Days (CBE-30) procedure. QDS implementation
began in May 2001 at Mississippi Valley.
Initial data from the MVRBC installation have confirmed, strengthened
and extended the findings of the Hoxworth study. Over 1000 MVRBC completed
donor and staff surveys showed extremely strong donor and staff
support for QDS. For example, compared to traditional donor-staff
interviews, donors with preferences preferred QDS by factors of four
or more for clarity, privacy, truthfulness, time satisfaction,
understanding and likelihood of donation again. Staff surveys showed
that among staff with an opinion the minimum strength of preference
is a factor of three compared to traditional face-to-face interviews
on faster for staff, more honest donor responses, more accurate
donor responses, more confidential donor answers, fewer staff
errors, and personal satisfaction. MVRBC studies also show
errors/omissions to be reduced by more than 60%. These SBIR-II study
findings were first presented at the AABB meeting in October 2001
and have since been expanded and presented elsewhere as detailed at References. In May 2002 QDS was updated to incorporate the
CBER mandated CJD/vCJD questions.
Second SBIR Grant - Paperless
Quality Donor System™ with Decision Making (HL072635)
Talisman won a second SBIR grant to develop a Paperless QDS with
Decision Making in January 2003. This grant was awarded under the
Fast Track program, in which the Phase I and Phase II grants are
approved at the same time. Phase II began in mid-2003 upon
completion of the Phase I work.
In Phase I, Talisman [1] developed an architectural design
for an integrated system that included vital signs and phlebotomy,
wide area networks, bar coding and archiving; [2] prototyped and
tested a vital signs module; [3] prototyped and tested electronic
data transfer with other blood center systems; [4] demonstrated
feasibility of developing decision aids to support staff
decision-making; [5] on an emergency basis developed two updates to
QDS to respond to FDA added requirements for questions regarding smallpox
vaccinations, SARS and West Nile Virus.
Talisman updated QDS well
within the FDA time requirements, and consistently faster than blood
centers were able to update their own procedures. The WNV changes
were accomplished in less than a week from issuance of the FDA
guidance.
During 2003, two more blood centers began to implement
QDS: West Tennessee Regional Blood Center (Jackson, TN) and
Lifeblood/Mid-South Blood Center (Memphis, TN). Late in 2003, CBER
advised Talisman that it must apply for a 510(k) marketing
clearance in order for blood centers to use interstate wide area
networks.
Talisman made substantial improvements in QDS to support larger
network configurations for efficiently. A subsystem was developed to
collect vital signs and phlebotomy information, the latter using
wireless handheld computers. This system was demonstrated at the
AABB Annual Meeting in November 2004. Also during this period, QDS
was extended to include a Spanish interview as well as English.
During 2004, Talisman developed an application for an FDA 510(k)
clearance for the QDS 2004 system, which clearance was granted by CBER/FDA in
October 2004. The company also developed a version of QDS that can
administer the donor health history interview over the Internet.
This capability is of interest to many employers that host blood
drives, on the expectation that employees can minimize time away
from their workstations by going to
the blood drive with the interview already completed. This Internet
interview capability has not been cleared by CBER. Finally, QDS was
updated to include the new Uniform Donor History Questionnaire
developed by AABB and approved by CBER, including supplemental
material and staff procedural flowcharts.
LifeShare Blood Centers (Shreveport, LA) and Dartmouth-Hitchcock
Medical Center (Lebanon, NH) began implementation of QDS in 2004.
Additional donor and staff satisfaction studies were conducted at
three blood centers. The results of these studies corroborated the
2001-2002 MVRBC data showing overwhelming donor and staff preference
for QDS on multiple dimensions.
In February 2005, a second article was published in
Transfusion describing the first 2 years of QDS use (2001-2002) at
Mississippi Valley Regional Blood Center. Further, two blood centers (MVRBC and West TN RBC) upgraded to
the new UDHQ early in the year. Other centers plan to upgrade during
the summer. Current work includes developing the Survey Research
System, a general system that allows easy development and deployment
of QDS-type AVT-CASI surveys on any subject.
|